Yaron Werber
Stock Analyst at TD Cowen
(2.51)
# 2,475
Out of 5,093 analysts
43
Total ratings
50%
Success rate
2.58%
Average return
Main Sectors:
Top Industries:
Stocks Rated by Yaron Werber
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| RARE Ultragenyx Pharmaceutical | Maintains: Buy | $86 → $75 | $36.19 | +107.24% | 3 | Nov 5, 2025 | |
| EXEL Exelixis | Maintains: Buy | $44 → $51 | $41.44 | +23.07% | 3 | Nov 5, 2025 | |
| ARGX argenx SE | Maintains: Buy | $800 → $1,146 | $898.02 | +27.61% | 4 | Oct 31, 2025 | |
| IONS Ionis Pharmaceuticals | Maintains: Buy | $59 → $99 | $78.97 | +25.36% | 2 | Oct 30, 2025 | |
| ALEC Alector | Downgrades: Hold | n/a | $1.29 | - | 1 | Oct 22, 2025 | |
| IOBT IO Biotech | Downgrades: Hold | n/a | $0.82 | - | 2 | Sep 30, 2025 | |
| ONC BeOne Medicines AG | Reiterates: Buy | $334 | $319.67 | +4.48% | 1 | Apr 24, 2025 | |
| FBRX Forte Biosciences | Initiates: Buy | n/a | $21.09 | - | 1 | Jan 21, 2025 | |
| DNTH Dianthus Therapeutics | Initiates: Buy | n/a | $43.63 | - | 1 | Dec 20, 2024 | |
| SEPN Septerna | Initiates: Buy | n/a | $25.33 | - | 1 | Nov 19, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $160 → $153 | $195.95 | -21.92% | 5 | Nov 15, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Hold | $132 → $122 | $94.72 | +28.80% | 5 | Nov 6, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | n/a | $28.52 | - | 1 | Nov 5, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $71 → $67 | $23.27 | +187.92% | 2 | Jul 15, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Buy | n/a | $35.21 | - | 1 | Mar 26, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Outperform | n/a | $1.87 | - | 1 | Mar 18, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Market Perform | n/a | $6.09 | - | 2 | Mar 15, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Outperform | n/a | $28.02 | - | 1 | Dec 20, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Market Perform | n/a | $5.36 | - | 1 | Oct 19, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Market Perform | $375 → $625 | $8.63 | +7,142.18% | 1 | Feb 28, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Market Perform | n/a | $11.34 | - | 2 | Nov 1, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Market Perform | $38 | $31.04 | +22.42% | 1 | May 2, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Outperform | n/a | $20.33 | - | 1 | Oct 26, 2021 |
Ultragenyx Pharmaceutical
Nov 5, 2025
Maintains: Buy
Price Target: $86 → $75
Current: $36.19
Upside: +107.24%
Exelixis
Nov 5, 2025
Maintains: Buy
Price Target: $44 → $51
Current: $41.44
Upside: +23.07%
argenx SE
Oct 31, 2025
Maintains: Buy
Price Target: $800 → $1,146
Current: $898.02
Upside: +27.61%
Ionis Pharmaceuticals
Oct 30, 2025
Maintains: Buy
Price Target: $59 → $99
Current: $78.97
Upside: +25.36%
Alector
Oct 22, 2025
Downgrades: Hold
Price Target: n/a
Current: $1.29
Upside: -
IO Biotech
Sep 30, 2025
Downgrades: Hold
Price Target: n/a
Current: $0.82
Upside: -
BeOne Medicines AG
Apr 24, 2025
Reiterates: Buy
Price Target: $334
Current: $319.67
Upside: +4.48%
Forte Biosciences
Jan 21, 2025
Initiates: Buy
Price Target: n/a
Current: $21.09
Upside: -
Dianthus Therapeutics
Dec 20, 2024
Initiates: Buy
Price Target: n/a
Current: $43.63
Upside: -
Septerna
Nov 19, 2024
Initiates: Buy
Price Target: n/a
Current: $25.33
Upside: -
Nov 15, 2024
Maintains: Buy
Price Target: $160 → $153
Current: $195.95
Upside: -21.92%
Nov 6, 2024
Maintains: Hold
Price Target: $132 → $122
Current: $94.72
Upside: +28.80%
Nov 5, 2024
Initiates: Buy
Price Target: n/a
Current: $28.52
Upside: -
Jul 15, 2024
Maintains: Buy
Price Target: $71 → $67
Current: $23.27
Upside: +187.92%
Mar 26, 2024
Upgrades: Buy
Price Target: n/a
Current: $35.21
Upside: -
Mar 18, 2024
Initiates: Outperform
Price Target: n/a
Current: $1.87
Upside: -
Mar 15, 2024
Downgrades: Market Perform
Price Target: n/a
Current: $6.09
Upside: -
Dec 20, 2023
Initiates: Outperform
Price Target: n/a
Current: $28.02
Upside: -
Oct 19, 2023
Downgrades: Market Perform
Price Target: n/a
Current: $5.36
Upside: -
Feb 28, 2023
Maintains: Market Perform
Price Target: $375 → $625
Current: $8.63
Upside: +7,142.18%
Nov 1, 2022
Downgrades: Market Perform
Price Target: n/a
Current: $11.34
Upside: -
May 2, 2022
Initiates: Market Perform
Price Target: $38
Current: $31.04
Upside: +22.42%
Oct 26, 2021
Initiates: Outperform
Price Target: n/a
Current: $20.33
Upside: -